Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
Part of paid clinical trials in Knoxville, Tennessee.
- Sponsor
- University of Tennessee Graduate School of Medicine
- Study ID
- NCT06800105
- Status
- Recruiting
Conditions
- Ovary Cancer
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- High fat smoothie — OTHERParticipants will consume a standardized 490 kcal high-fat smoothie, consisting of 57% fat, 23% carbohydrate, and 20% protein.
Study Details
Minimal information is available regarding changes in whole-body metabolism in ovarian cancer patients, and no study has assessed whole-body lipid metabolism in this patient population. In this pilot study we will assess fasting and postprandial lipid metabolism of ovarian cancer patients before, during, and after treatment via indirect calorimetry.
Key Dates
- Start date
- Mar 22, 2023
- Status verified
- Jan 2025
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 10 participants (estimated)
Arms
- Arm: Patients with presumed ovarian cancerPatients with presumed ovarian cancer will complete three, 4-hour study visits at the following time points: * The 1st visit will occur before treatment. * The 2nd visit will occur after about half of the planned treatment as been completed. * The 3rd visit will occur 4-8 weeks after the completion of treatment.
Primary Outcome Measure
Feasibility assessed by attrition [ Time Frame: 60 months ]
Central Contacts
- Jill M Maples, PhD8653059367
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Tennessee Graduate School of Medicine | Knoxville | Tennessee | 37920 | Jill M Maples, PhD |
Find similar trials in Knoxville, TN
Related Studies
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionPHASE1/PHASE2 · Recruiting · A2 Biotherapeutics Inc. · Gilbert, Arizona
- Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)Recruiting · Northwestern University · Chicago, Illinois
- An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and OlaparibPHASE2 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Alternate Day Fasting After Surgery for Patients Undergoing ChemotherapyRecruiting · Northwestern University · Chicago, Illinois